Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CytomX Therapeutics Inc (DE:6C1)
FRANKFURT:6C1
CytomX Therapeutics (6C1) Ownership - Who Owns CytomX Therapeutics?
0 Followers
CytomX Therapeutics (6C1) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.94% Other Institutional Investors
99.06% Public Companies and
Individual Investors
The ownership structure of CytomX Therapeutics (DE:6C1) stock is a mix of institutional, retail and individual investors. Approximately 0.94% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 99.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 28, 2024 | Sean A. Mccarthy Ceo,director | Bought | $172336 |
| Mar 21, 2024 | Sean A. Mccarthy Ceo,director | Sold | $42064 |
| Mar 21, 2024 | Sold | $10957 | |
| Mar 21, 2024 | Marcia Belvin Svp, Chief Scientific Officer | Sold | $26614 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,132,025 | Institution | ― | 5,167,841 | |
| 142,894 | Institution | ― | 235,775 | |
| 118,163 | Institution | ― | 194,969 | |
| 282,099 | Institution | ― | 465,463 | |
| 21 | Institution | ― | 35 | |
| 14,447 | Institution | ― | 23,838 | |
| 106,678 | Institution | ― | 176,019 | |
| 51,570 | Institution | ― | 85,091 | |
| 434,524 | Institution | ― | 716,965 | |
| 26,159 | Institution | ― | 43,162 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21 | Institution | ― | 35 | |
| 14,447 | Institution | ― | 23,838 | |
| 106,678 | Institution | ― | 176,019 | |
| 51,570 | Institution | ― | 85,091 | |
| 434,524 | Institution | ― | 716,965 | |
| 26,159 | Institution | ― | 43,162 | |
| 41,458 | Institution | ― | 68,406 | |
| 1,192 | Institution | ― | 1,967 | |
| 555,119 | Institution | ― | 915,946 | |
| 3,128,783 | Institution | ― | 5,162,492 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns CytomX Therapeutics Inc (DE:6C1)?
According to the latest TipRanks data, approximately 0.94% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 99.06% is held by retail investors.
What percentage of CytomX Therapeutics Inc (DE:6C1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.94% of CytomX Therapeutics Inc (DE:6C1) stock is held by institutional investors.
What percentage of CytomX Therapeutics Inc (DE:6C1) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.06% of CytomX Therapeutics Inc (DE:6C1) stock is held by retail investors.
Who owns the most shares of CytomX Therapeutics Inc (DE:6C1)?
Vanguard owns the most shares of CytomX Therapeutics Inc (DE:6C1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.